Skip to main content
Clinical Trials/NCT04212182
NCT04212182
Unknown
Not Applicable

The Physiological Effect of High Flow Oxygen Therapy on Acute Exacerbation of Chronic Obstructive Pulmonary Disease

The First Affiliated Hospital of Guangzhou Medical University1 site in 1 country10 target enrollmentDecember 27, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
High-flow Nasal Cannula
Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Enrollment
10
Locations
1
Primary Endpoint
Neural respiratory drive
Last Updated
6 years ago

Overview

Brief Summary

Although non-invasive positive pressure ventilation (NPPV) shows the good curative effect of treating the patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), some patients do not tolerate NPPV or do not benefit from it. High-flow nasal cannula (HFNC) is well tolerated and may be used to patients with AECOPD who are intolerant to NPPV treatment. This study is to evaluate the physiological effect of HFNC and compare it with NPPV.

Registry
clinicaltrials.gov
Start Date
December 27, 2019
End Date
July 1, 2020
Last Updated
6 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Sponsor
The First Affiliated Hospital of Guangzhou Medical University
Responsible Party
Principal Investigator
Principal Investigator

Rongchang Chen

Principal Investigator

The First Affiliated Hospital of Guangzhou Medical University

Eligibility Criteria

Inclusion Criteria

  • AECOPD patients with acute hypercapnic respiratory failure

Exclusion Criteria

  • other lung/pleural diseases or thoracic deformity
  • severe heart failure (New York Heart Association class IV), severe dysrhythmia
  • unstable angina, or malignant comorbidity
  • obesity (BMI ≥ 35 kg/m²)
  • severe obstructive sleep apnea syndrome

Outcomes

Primary Outcomes

Neural respiratory drive

Time Frame: 30 minutes

Neural respiratory drive is calculated by diaphragm electromyogram

Secondary Outcomes

  • Work of breathing(30 minutes)
  • Transcutaneous CO2(30 minutes)

Study Sites (1)

Loading locations...

Similar Trials